NORTHERN TRUST CORP - NGM BIOPHARMACEUTICALS INC ownership

NGM BIOPHARMACEUTICALS INC's ticker is NGM and the CUSIP is 62921N105. A total of 82 filers reported holding NGM BIOPHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 1.4%.

Quarter-by-quarter ownership
NORTHERN TRUST CORP ownership history of NGM BIOPHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$368,156
-59.7%
344,071
-2.5%
0.00%
Q2 2023$914,399
-36.7%
353,050
-0.3%
0.00%
Q1 2023$1,444,410
-16.5%
354,022
+2.7%
0.00%
Q4 2022$1,730,290
-61.0%
344,679
+1.7%
0.00%
-100.0%
Q3 2022$4,434,000
+1.3%
339,071
-0.6%
0.00%0.0%
Q2 2022$4,375,000
-2.1%
341,251
+16.4%
0.00%0.0%
Q1 2022$4,470,000
-17.1%
293,106
-3.7%
0.00%0.0%
Q4 2021$5,394,000
-14.3%
304,514
+1.7%
0.00%0.0%
Q3 2021$6,295,000
+7.3%
299,460
+0.7%
0.00%0.0%
Q2 2021$5,866,000
-26.3%
297,440
+8.6%
0.00%0.0%
Q1 2021$7,960,000
-2.5%
273,840
+1.6%
0.00%
-50.0%
Q4 2020$8,164,000
+86.1%
269,472
-2.3%
0.00%
+100.0%
Q3 2020$4,386,000
-15.1%
275,696
+5.4%
0.00%0.0%
Q2 2020$5,165,000
+58.4%
261,639
-1.0%
0.00%0.0%
Q1 2020$3,260,000
-32.8%
264,402
+0.8%
0.00%0.0%
Q4 2019$4,849,000
+246.1%
262,239
+159.1%
0.00%
Q3 2019$1,401,000
+107.6%
101,211
+119.7%
0.00%
Q2 2019$675,00046,0660.00%
Other shareholders
NGM BIOPHARMACEUTICALS INC shareholders Q3 2020
NameSharesValueWeighting ↓
Column Group LLC 15,396,116$303,611,00042.97%
Ponoi II Management, LLC 1,298,908$25,614,00020.76%
Ponoi Management, LLC 1,298,908$25,614,00014.23%
Euclidean Capital LLC 1,493,349$29,449,0009.56%
RHO CAPITAL PARTNERS INC 3,766,666$74,279,0006.80%
Aquilo Capital Management, LLC 1,194,237$23,550,0006.12%
Greenspring Associates, LLC 1,573,357$31,027,0002.10%
Octagon Capital Advisors LP 200,000$3,944,0000.82%
Redmile Group, LLC 2,792,448$55,067,0000.82%
BVF INC/IL 955,000$18,833,0000.71%
View complete list of NGM BIOPHARMACEUTICALS INC shareholders